How Death After Circulatory Stoppage Is Revolutionizing Organ Donations

Organ transplants are saving more lives than ever, yet demand still far outstrips supply. In 2021, over 49,000 transplants took place in the U.S., but more than 100,000 people remained on waiting lists. A growing share of these life-saving donations now comes from a method called donation after circulatory death (DCD), which has surged from just 2% of cases in 2000 to nearly half by 2021.

DCD differs from traditional brain-death donation. Instead of relying on neurological criteria, death is confirmed after the heart permanently stops beating. Doctors must wait at least five minutes before retrieving organs, ensuring the process is irreversible. This method has become the main source of deceased-donor transplants in the U.S., helping to close the gap between supply and need.

Yet DCD also raises concerns. Rare but unsettling reports describe potential donors showing unexpected signs of life, prompting calls for stricter safeguards. New policies are now being proposed to strengthen oversight and rebuild public trust in the system.

To improve organ quality, hospitals use a technique called normothermic regional perfusion. This temporarily restores blood flow to the organs after death, keeping them viable for longer. While DCD rates vary across the country, experts suggest better education for hospitals and families could increase donations further. No state-specific data on DCD rates is currently available, but the trend shows steady growth nationwide.

The rise of DCD has already expanded the number of available organs, offering hope to thousands on waiting lists. With improved safeguards and clearer public communication, this method could help save even more lives. The focus now shifts to refining protocols and ensuring every viable donation opportunity is used.